Valuation: Olympus Corporation

Market Cap 1,932B 12.12B 10.54B 9.81B 9.01B 17.01B 1,157B 17.27B 116B 45.38B 576B 45.53B 44.53B P/E 2027 *
20x
P/E 2028 * 16.7x
Enterprise Value 1,998B 12.54B 10.9B 10.14B 9.31B 17.59B 1,197B 17.86B 120B 46.93B 596B 47.08B 46.05B EV / Sales 2027 *
1.87x
EV / Sales 2028 * 1.79x
Free-Float
94.53%
Yield 2027 *
1.69%
Yield 2028 * 1.77%
1 day-0.05%
1 week+0.30%
Current month-0.05%
1 month+2.88%
3 months+18.54%
6 months-3.53%
Current year-8.34%
1 week 1,761
Extreme 1761
1,887.5
1 month 1,703
Extreme 1703
1,887.5
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%+0.30%+1.56%-19.10% 12.13B
+1.11%+1.06%+24.03%+3.71% 212B
+2.01%+1.82%-1.07%-24.39% 137B
+5.70%+4.69%-26.86%+12.57% 125B
+3.66%+5.60%-55.67%-7.68% 69.46B
+2.34%+4.16%+8.50%+7.08% 49.56B
+6.54%+7.82%-17.08%-20.95% 47.2B
+0.86%-0.14%+21.91%+8.35% 39.08B
+0.73%+0.70%+29.97%+29.32% 37.05B
-0.24%+5.67%+116.67%+8.20% 30.97B
Average +0.54%+3.39%+10.19%-0.29% 75.97B
Weighted average by Cap. +0.40%+2.84%+3.88%-0.95%

Financials

2027 *2028 *
Net sales 1,068B 6.7B 5.83B 5.42B 4.98B 9.4B 640B 9.55B 63.91B 25.08B 318B 25.17B 24.61B 1,108B 6.95B 6.04B 5.63B 5.17B 9.75B 664B 9.9B 66.31B 26.03B 330B 26.11B 25.54B
Net income 98.69B 619M 538M 501M 460M 869M 59.12B 882M 5.91B 2.32B 29.43B 2.33B 2.27B 117B 735M 639M 595M 546M 1.03B 70.18B 1.05B 7.01B 2.75B 34.94B 2.76B 2.7B
Net Debt 65.76B 413M 359M 334M 307M 579M 39.39B 588M 3.94B 1.54B 19.61B 1.55B 1.52B 56.53B 355M 308M 287M 264M 498M 33.86B 505M 3.38B 1.33B 16.86B 1.33B 1.3B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-08-03 ¥1,819.00 -0.05% 4,210,500
26-07-31 ¥1,820.00 -2.02% 5,361,000
26-07-30 ¥1,857.50 -0.27% 3,701,100
26-07-29 ¥1,862.50 +3.36% 5,946,400
26-07-28 ¥1,802.00 -0.63% 3,909,500
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,820.00JPY
Average target price
1,916.92JPY
Spread / Average Target
+5.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock